Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Apr;63(4):602–608. doi: 10.1172/JCI109342

Pre- and Postoperative Studies of Plasma Calcitonin in Primary Hyperparathyroidism

Phillip W Lambert 1,2, Hunter Heath III 1,2, Glen W Sizemore 1,2
PMCID: PMC371994  PMID: 438324

Abstract

The importance of calcitonin in the homeostatic response to the chronic hypercalcemia of primary hyperparathyroidism is uncertain. To clarify this issue, we have used a new, sensitive radioimmunoassay for human calcitonin to measure basal plasma calcitonin concentrations in 50 patients with primary hyperparathyroidism (32 female, 18 male). We assayed calcium-stimulated calcitonin concentrations preoperatively in 22 of the patients (16 female, 6 male) and postoperatively in 6. Finally, we assayed pentagastrin-stimulated calcitonin concentrations preoperatively in eight of the patients (three female, five male). Plasma calcitonin values after an overnight fast were indistinguishable from those in normal subjects (mean±SE, males, 48±3 normal and 46±5 pg/ml hyperparathyroid, females, 31±2 normal and 37±3 pg/ml hyperparathyroid.) Among hyperparathyroid patients of both sexes, increases of calcitonin during Ca infusion (15 mg Ca/kg in 4 h) were within normal limits. However, the mean maximal increase of calcitonin was significantly lower in hyperparathyroid than in normal subjects (P < 0.05). In six patients normocalcemic 5-15 mo after parathyroid surgery, fasting plasma calcitonin values were not significantly different, but responses to Ca infusion were greater than preoperatively (Δ calcitonin ±SE: 13±4 preoperatively and 53±35 pg/ml postoperatively). The mean maximal increase of calcitonin after pentagastrin (0.5 μg/kg i.v.) was slightly lower than normal in the patients (mean±SE, males, 45±8 normal and 38±10 pg/ml hyperparathyroid, females, 6±2 normal and 0 pg/ml hyperparathyroid). Thus, primary hyperparathyroidism is accompanied by normal steady-state concentrations of circulating calcitonin, and normal-to-blunted C-cell responses to pentagastrin or induced hypercalcemia, the response to calcium generally increasing after successful parathyroid surgery. These results clearly show that primary hyperparathyroidism is not characterized by hypercalcitoninemia. The seemingly paradoxical absence of elevated steady-state calcitonin concentrations may be accounted for partly by decreased secretory reserve. However, primary hyperparathyroidism may also be accompanied by an increase in the threshold of sensitivity for calcium stimulation of calcitonin secretion.

Full text

PDF
602

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi I., Abe K., Tanaka M., Yamaguchi K., Miyakawa S. Plasma human calcitonin (hCT) levels in normal and pathologic conditions, and their responses to short calcium or tetragastrin infusion. Endocrinol Jpn. 1976 Dec;23(6):517–526. doi: 10.1507/endocrj1954.23.517. [DOI] [PubMed] [Google Scholar]
  2. Arnaud C. D., Tsao H. S., Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest. 1971 Jan;50(1):21–34. doi: 10.1172/JCI106476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baylin S. B., Bailey A. L., Hsu T. H., Foster G. V. Degradation of human calcitonin in human plasmas. Metabolism. 1977 Dec;26(12):1345–1354. doi: 10.1016/0026-0495(77)90030-0. [DOI] [PubMed] [Google Scholar]
  4. Coombes R. C., Hillyard C., Greenberg P. B., MacIntyre I. Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet. 1974 Jun 1;1(7866):1080–1083. doi: 10.1016/s0140-6736(74)90557-1. [DOI] [PubMed] [Google Scholar]
  5. Deftos L. J., Bury A. E., Habener J. F., Singer F. R., Potts J. T., Jr Immunoassay for human calcitonin. II. Clinical studies. Metabolism. 1971 Dec;20(12):1129–1137. doi: 10.1016/0026-0495(71)90038-2. [DOI] [PubMed] [Google Scholar]
  6. Deftos L. J., Powell D., Parthemore J. G., Potts J. T., Jr Secretion of calcitonin in hypocalcemic states in man. J Clin Invest. 1973 Dec;52(12):3109–3114. doi: 10.1172/JCI107510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deftos L. J., Roos B. A., Bronzert D., Parthemore J. G. Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab. 1975 Mar;40(3):409–412. doi: 10.1210/jcem-40-3-409. [DOI] [PubMed] [Google Scholar]
  8. Deftos L. J., Roos B. A., Parthemore J. G. Calcium and skeletal metabolism. West J Med. 1975 Dec;123(6):447–458. [PMC free article] [PubMed] [Google Scholar]
  9. Gittes R. F., Toverud S. U., Cooper C. W. Effects of hypercalcemia and hypocalcemia on the thyrocalcitonin content of rat thyroid glands. Endocrinology. 1968 Jan;82(1):83–90. doi: 10.1210/endo-82-1-83. [DOI] [PubMed] [Google Scholar]
  10. Heath H., 3rd, Sizemore G. W. Plasma calcitonin in normal man. Differences between men and women. J Clin Invest. 1977 Nov;60(5):1135–1140. doi: 10.1172/JCI108865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Heynen G., Franchimont P. Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest. 1974 Jun;4(3):213–222. doi: 10.1111/j.1365-2362.1974.tb00395.x. [DOI] [PubMed] [Google Scholar]
  12. Hillyard C. J., Cooke T. J., Coombes R. C., Evans I. M., Macintyre I. Normal plasma calcitonin: circadian variation and response to stimuli. Clin Endocrinol (Oxf) 1977 Apr;6(4):291–298. doi: 10.1111/j.1365-2265.1977.tb02014.x. [DOI] [PubMed] [Google Scholar]
  13. LiVolsi V. A., Feind C. R., LoGerfo P., Tashjian A. H., Jr Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism. J Clin Endocrinol Metab. 1973 Oct;37(4):550–559. doi: 10.1210/jcem-37-4-550. [DOI] [PubMed] [Google Scholar]
  14. Ljungberg O., Dymling J. F. Pathogenesis of C-cell neoplasia in thyroid gland. C-cell proliferation in a case of chronic hypercalcaemia. Acta Pathol Microbiol Scand A. 1972;80(5):577–588. doi: 10.1111/j.1699-0463.1972.tb00319.x. [DOI] [PubMed] [Google Scholar]
  15. Morita R., Fukunaga M., Yamamoto I., Mori T., Torizuka K. Radioimmunoassay for human calcitonin employing synthetic calcitonin M: its clinical application. Endocrinol Jpn. 1975 Oct;22(5):419–426. doi: 10.1507/endocrj1954.22.419. [DOI] [PubMed] [Google Scholar]
  16. Parthemore J. G., Deftos L. J., Bronzert D. The regulation of calcitonin in normal human plasma as assessed by immunoprecipitation and immunoextraction. J Clin Invest. 1975 Oct;56(4):835–841. doi: 10.1172/JCI108162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Silva O. L., Becker K. L., Doppman J. L., Snider R. H., Moore C. F. Calcitonin levels in thyroid-vein blood of man. Am J Med Sci. 1975 Jan-Feb;269(1):37–41. doi: 10.1097/00000441-197501000-00005. [DOI] [PubMed] [Google Scholar]
  18. Silva O. L., Snider R. H., Becker K. L. Radioimmunoassay of calcitonin in human plasma. Clin Chem. 1974 Mar;20(3):337–339. [PubMed] [Google Scholar]
  19. Singer F. R., Habener J. F. Multiple immunoreactive forms of calcitonin in human plasma. Biochem Biophys Res Commun. 1974 Nov 27;61(2):710–716. doi: 10.1016/0006-291x(74)91015-8. [DOI] [PubMed] [Google Scholar]
  20. Sizemore G. W., Hpeath H., 3rd, Larson J. M. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma. J Clin Invest. 1975 May;55(5):1111–1118. doi: 10.1172/JCI108012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Snider R. H., Silva O. L., Moor C. F., Becker K. L. Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoassay. Clin Chim Acta. 1977 Apr 1;76(1):1–14. doi: 10.1016/0009-8981(77)90113-9. [DOI] [PubMed] [Google Scholar]
  22. Tashjian A. H., Jr, Frantz A. G., Lee J. B. Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1138–1142. doi: 10.1073/pnas.56.4.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tashjian A. H., Jr, Voelkel E. F. Decreased thyrocalcitonin in thyroid glands from patients with hyperparathyroidism. J Clin Endocrinol Metab. 1967 Sep;27(9):1353–1357. doi: 10.1210/jcem-27-9-1353. [DOI] [PubMed] [Google Scholar]
  24. Vora N. M., Williams G. A., Hargis G. K., Bowser E. N., Kawahara W., Jackson B. L., Henderson W. J., Kukreja S. C. Comparative effect of calcium and of the adrenergic system on calcitonin secretion in man. J Clin Endocrinol Metab. 1978 Apr;46(4):567–571. doi: 10.1210/jcem-46-4-567. [DOI] [PubMed] [Google Scholar]
  25. Young D. M., Capen C. C. Thyrocalcitonin content of thyroid glands from cows with Vitamin D-induced hypercalcemia. Endocrinology. 1970 Jun;86(6):1463–1466. doi: 10.1210/endo-86-6-1463. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES